140 related articles for article (PubMed ID: 3932459)
1. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms.
Larson TA; Peterson LR; Gerding DN
J Clin Microbiol; 1985 Nov; 22(5):819-21. PubMed ID: 3932459
[TBL] [Abstract][Full Text] [Related]
2. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli with a cation-supplemented inoculum.
Cherne JE; Peterson LR
Antimicrob Agents Chemother; 1980 Jul; 18(1):210-1. PubMed ID: 6774664
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin.
Woolfrey BF; Lally RT; Quall CO
J Clin Microbiol; 1983 Feb; 17(2):312-6. PubMed ID: 6403574
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin.
Woolfrey BF; Lally RT; Ederer MN; Quall CO
J Clin Microbiol; 1984 Apr; 19(4):502-5. PubMed ID: 6425360
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.
Clark RB; Sanders CC; Pakiz CB; Hostetter MK
Antimicrob Agents Chemother; 1988 May; 32(5):689-92. PubMed ID: 3134846
[TBL] [Abstract][Full Text] [Related]
7. Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.
Staneck JL; Glenn S; DiPersio JR; Leist PA
J Clin Microbiol; 1989 Oct; 27(10):2277-85. PubMed ID: 2511223
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
Ismaeel NA
Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of aminoglycoside resistance. European data.
Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
[TBL] [Abstract][Full Text] [Related]
10. An analysis of error rates for disc agar-diffusion testing of Pseudomonas aeruginosa versus aminoglycosides.
Woolfrey BF; Fox JM; Quall CO
Am J Clin Pathol; 1981 Apr; 75(4):559-64. PubMed ID: 6784571
[TBL] [Abstract][Full Text] [Related]
11. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
Stratton CW; Weeks LS; Tausk F
J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
13. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
Marks MI; Hammerberg S; Greenstone G; Silver B
Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
[TBL] [Abstract][Full Text] [Related]
14. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
Daschner FD; Steffens A; Langmaack H
Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
[TBL] [Abstract][Full Text] [Related]
15. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
Minshew BH; Pollock HM; Schoenknecht FD; Sherris JC
Antimicrob Agents Chemother; 1977 Dec; 12(6):688-96. PubMed ID: 412464
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
17. Comparative evaluation of five aminoglycosides for treatment.
Rosin H; Naumann P; Reintjens E; Köhler M
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.
Hindler JA; Bruckner DA
J Clin Microbiol; 1987 Mar; 25(3):546-50. PubMed ID: 3571458
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
Angehrn P
Eur J Clin Microbiol; 1983 Oct; 2(5):489-95. PubMed ID: 6315424
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
Meyer RD; Draus LL; Pasieczinik KA
Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
